Two functionally similar but mechanistically independent mechanisms related to the type I IFN response, i.e. neutralizing autoantibodies against type I IFNs (19) and inborn errors of TLR3- and IRF7-dependent type I IFN immunity (6), have been demonstrated to be associated with severe COVID-19. The gene discussed is TLR3; the disease is COVID-19.